avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gli3
|
ENSMUSG00000021318.9 | GLI-Kruppel family member GLI3 |
Zic1
|
ENSMUSG00000032368.8 | zinc finger protein of the cerebellum 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gli3 | mm10_v2_chr13_+_15463837_15463980 | 0.81 | 2.0e-09 | Click! |
Zic1 | mm10_v2_chr9_-_91365778_91365815 | 0.49 | 2.5e-03 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 21.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.4 | 7.1 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
2.2 | 11.2 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.9 | 5.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
1.7 | 5.0 | GO:0045660 | positive regulation of neutrophil differentiation(GO:0045660) |
1.4 | 5.6 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.1 | 3.4 | GO:0030221 | basophil differentiation(GO:0030221) |
1.1 | 4.4 | GO:0060032 | notochord regression(GO:0060032) |
1.0 | 3.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) regulation of establishment of T cell polarity(GO:1903903) |
1.0 | 5.9 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.0 | 9.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 11.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.9 | 3.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.8 | 0.8 | GO:0060915 | fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
0.8 | 2.3 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.7 | 4.4 | GO:0032796 | uropod organization(GO:0032796) |
0.7 | 2.0 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.7 | 2.6 | GO:0072054 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) renal outer medulla development(GO:0072054) inner medullary collecting duct development(GO:0072061) |
0.6 | 1.9 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.6 | 9.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.6 | 4.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.6 | 4.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.6 | 3.5 | GO:0051790 | acetate metabolic process(GO:0006083) short-chain fatty acid biosynthetic process(GO:0051790) |
0.5 | 3.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 13.5 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.5 | 2.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 2.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 2.5 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 2.9 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.5 | 8.4 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.5 | 14.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.5 | 1.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 1.4 | GO:2001076 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
0.4 | 1.3 | GO:1904978 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.4 | 2.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 1.2 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.4 | 3.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.8 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 2.1 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 1.8 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.3 | 9.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 7.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 2.3 | GO:0030421 | defecation(GO:0030421) |
0.3 | 0.3 | GO:1904907 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.3 | 4.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 2.8 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.3 | 0.9 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.3 | 8.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.3 | 1.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 4.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.3 | 1.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 1.1 | GO:1904504 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 1.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 11.4 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 1.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 1.0 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.0 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 1.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 2.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 2.6 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.2 | 0.9 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 1.3 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 3.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.7 | GO:0071288 | cellular response to mercury ion(GO:0071288) cellular response to water stimulus(GO:0071462) |
0.2 | 1.3 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 4.3 | GO:0007614 | short-term memory(GO:0007614) |
0.2 | 0.6 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 0.2 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.2 | 1.1 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.5 | GO:0036292 | DNA rewinding(GO:0036292) |
0.2 | 2.9 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 1.7 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.8 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.3 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.2 | 1.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 2.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.8 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.2 | 0.8 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 0.3 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 7.8 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.2 | 2.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 3.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.4 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 1.3 | GO:0071231 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.1 | 1.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 3.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 2.6 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.9 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 0.5 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.1 | 2.1 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 3.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 1.6 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 0.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 1.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 1.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 1.8 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 8.3 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 0.7 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.4 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.1 | 0.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 1.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.1 | 0.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.1 | 1.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 1.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 1.9 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 1.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.1 | 1.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.2 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.1 | 0.3 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 1.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.1 | 3.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 2.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 1.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 1.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.8 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 2.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.3 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
0.1 | 1.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 3.8 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.1 | 1.2 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.5 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.7 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 4.2 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.0 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.0 | 0.5 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 1.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 1.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 1.0 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.4 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 1.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 2.3 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.0 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.0 | 1.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 1.1 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.0 | 0.1 | GO:1905034 | regulation of defense response to fungus(GO:1900150) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.0 | 0.6 | GO:0090382 | phagosome maturation(GO:0090382) |
0.0 | 3.2 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.0 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 2.4 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.0 | 0.1 | GO:0097240 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.0 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 1.0 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.6 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.3 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 1.0 | GO:0051591 | response to cAMP(GO:0051591) |
0.0 | 0.3 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.7 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.0 | 0.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.5 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.7 | 11.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.2 | 3.6 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.8 | 2.3 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
0.8 | 3.1 | GO:0045160 | myosin I complex(GO:0045160) |
0.7 | 2.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 8.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 12.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 1.8 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.4 | 12.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 0.9 | GO:0043259 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) |
0.4 | 3.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 3.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 9.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 4.4 | GO:0097542 | ciliary tip(GO:0097542) |
0.3 | 4.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 0.9 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.3 | 2.3 | GO:0030478 | actin cap(GO:0030478) |
0.3 | 1.0 | GO:0099522 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
0.3 | 1.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 4.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 2.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.2 | 1.1 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.2 | 2.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 4.9 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 3.3 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.9 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 2.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 4.0 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.7 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 1.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 1.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 9.9 | GO:0014704 | intercalated disc(GO:0014704) |
0.1 | 0.8 | GO:0001652 | granular component(GO:0001652) |
0.1 | 2.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 2.1 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 1.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 2.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.3 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.1 | 3.8 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.0 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 5.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 1.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 0.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 2.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 1.9 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.6 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 3.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 0.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 7.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.0 | 3.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 15.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.6 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.0 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 5.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 2.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 2.9 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.1 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 7.0 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 3.1 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 3.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.2 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 1.1 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 1.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.6 | 11.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.2 | 3.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.1 | 10.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 4.2 | GO:2001069 | glycogen binding(GO:2001069) |
1.0 | 3.1 | GO:0045159 | myosin II binding(GO:0045159) |
1.0 | 5.8 | GO:0015265 | urea channel activity(GO:0015265) |
0.9 | 2.6 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.8 | 2.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.8 | 3.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 3.7 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.7 | 2.6 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.6 | 23.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 4.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.5 | 5.6 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 8.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 2.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.4 | 6.6 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 9.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.4 | 8.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 2.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.4 | 1.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.3 | 1.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 1.6 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 0.9 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 1.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 1.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) bradykinin receptor binding(GO:0031711) |
0.3 | 2.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 1.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.3 | 1.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.3 | 4.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.6 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.2 | 2.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.2 | 1.8 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.2 | 0.7 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.2 | 3.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 4.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 9.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 1.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 2.0 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 3.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 5.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 3.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 1.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 4.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 2.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 2.2 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 12.3 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.8 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 1.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 1.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 1.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.1 | 0.7 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.6 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 1.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.2 | GO:0009041 | uridylate kinase activity(GO:0009041) nucleoside phosphate kinase activity(GO:0050145) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.4 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 1.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 3.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.4 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 2.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 9.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 4.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.0 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 1.1 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 9.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 3.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 1.3 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 1.9 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.0 | 1.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 1.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 17.8 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.6 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.4 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 6.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 1.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 1.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 2.5 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.2 | 11.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 12.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 8.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 4.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 4.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 3.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 3.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 4.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 1.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 3.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 2.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 3.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 6.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 2.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 2.0 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 2.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 2.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 5.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 10.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
1.1 | 22.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.7 | 8.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.6 | 3.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 14.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 9.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 2.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 3.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 4.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 4.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 1.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 3.1 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 2.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 2.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 10.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 1.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 4.9 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 3.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 11.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 5.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 4.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.0 | 0.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 2.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 1.9 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 2.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |